Stay updated on INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the page. This reflects maintenance rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:08:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    IPD sharing language was added, outlining access for researchers, conditions for data sharing, and how to request IPD via Vivli. It also references related privacy protections and public availability timelines.
    Difference
    0.4%
    Check dated 2026-08-25T20:19:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor patch to the page's metadata.
    Difference
    0.0%
    Check dated 2026-08-11T18:33:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a small platform update that does not alter the study details or displayed content.
    Difference
    0.0%
    Check dated 2026-07-28T14:40:36.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Added external registry identifiers JapicCTI-194983, NMRR-19-1491-48537, jRCT2080224898, and CTR20192589 to the study record. Removed older milestone dates (2026-02-27, 2026-02-26, 2026-02, 2026-05-01) and added new dates (2026-07-13, 2026-06-17, 2026-06, 2026-12-31).
    Difference
    0.2%
    Check dated 2026-07-14T06:53:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the page content. This update reflects an updated release of study documents and related UI elements.
    Difference
    0.0%
    Check dated 2026-07-07T00:41:00.000Z thumbnail image

Stay in the know with updates to INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INSIGHT 2: Tepotinib+Osimertinib in MET+ NSCLC Clinical Trial page.